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Glenn M. LaMuraglia, MD, Michael Corey, BA, Suhny Abbara, MD, and Richard P. Cambria,
MD, Boston, Mass
Objective: In multiple comparisons of open vs endovascular (EVAR) repair of abdominal aortic aneurysms, the prior
assumption that open repair produced superior durability has been challenged by advocates of EVAR. Although focus on
EVAR reintervention has been intense, few contemporary studies document late outcomes after open repair; this was the
goal of this study.
Methods: From January 1994 to December 1998 (chosen to ensure a minimum 5-year follow-up), 540 patients underwent
elective open repair. Surveillance imaging (computed tomographic and magnetic resonance imaging scans) was obtained
for 152 (57%) of the 269 patients who remained alive at a mean follow-up of 87 months. Study end points included
freedom from graft-related interventions and aneurysm-related and overall survival (Kaplan-Meier test); factors predic-
tive of these end points were determined by multivariate analysis.
Results: The mean age at operation was 73 years. A total of 76% of patients were male; 11% had renal insufficiency
(creatinine >1.5 mg/dL), and 13% had chronic obstructive pulmonary disease. The aortic cross-clamp position was
suprarenal in 135 (25%) patients, and 284 (53%) of patients had bifurcated grafts placed. Operative mortality (30 days)
was 3%, and the median length of hospital stay was 7 days. Postoperative complications occurred in 68 (13%) patients.
Predictors of postoperative complications included a history of myocardial infarction (hazard ratio [HR], 2.0; P  .01)
and renal insufficiency (HR, 2.5; P  .02). The mean follow-up for all patients was 87 months. Actuarial survival was
70.7%  2% and 44.3%  2.4% at 5 and 10 years, respectively. Negative predictors of long-term survival included
advanced age (HR, 1.1; P< .001), history of myocardial infarction (HR, 1.37; P .02), and renal insufficiency (HR, 1.5;
P .04). Freedom from graft-related reintervention was 98.2% 0.8% and 94.3% 3.4% at 5 and 10 years, respectively.
There were 13 late graft-related complications in 11 (2%) patients (mean follow-up, 7.2 years). Findings included seven
anastomotic pseudoaneurysms (five were repaired), four graft limb occlusions, and two graft infections. Aneurysms were
identified in noncontiguous arterial segments in 68 (45%) of 152 patients, most of which involved the iliac arteries and
required no treatment because of small size. Late aortic aneurysms proximal to the repair were identified in 24% of
patients, and 29 (19%) patients had multiple late synchronous aneurysms.
Conclusions: Open repair remains a safe and durable option for the management of abdominal aortic aneurysms, with an
excellent associated 10-year survival in patients who undergo operation at 75 years of age or younger. In addition, the
freedom from graft-related reintervention is superior to that of EVAR. Finally, continued surveillance after open repair
is appropriate and should be directed toward the detection of other aneurysms. (J Vasc Surg 2007;46:669-75.)The first successful resection of an abdominal aortic
aneurysm (AAA) was reported by Dubost et al1 in 1952.
Subsequent refinements in the open surgical approach have
made it the gold standard of therapy for AAA repair.2,3
Nearly four decades later, Parodi et al4 reported the first
endovascular aneurysm repair (EVAR), thus heralding a
new era in the treatment of AAA. Since then, continuing
technological advances have made EVAR not only feasible
at most institutions, but also the first-line therapy for AAA
repair in anatomically suitable patients.5-9 Indeed, in 2005,
70% of AAA repairs at our institution were performed with
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lished early safety and efficacy of EVAR, as evidenced by
high technical success rates and low perioperative morbid-
ity and mortality.6,10-12 In addition, although a recent
study from our institution revealed an overall 11% reinter-
vention rate after EVAR, this number has improved with
the use of more contemporary devices.10 Because of the
favorable results of EVAR, open surgery as the standard of
care for AAA is being called into question; indeed, some
have challenged the tacit assumption that freedom from
reintervention, ie, durability considerations, favor open
operation.5 Although focus on EVAR reintervention has
been intense, few contemporary studies report late out-
comes after open repair.13-16 The goal of this study was to
document the long-term results of a contemporary series of
open AAA repair before the wide application of EVAR.
METHODS
From January 1, 1994, to December 30, 1998 (chosen
to ensure a minimal 5-year follow-up and predate the
widespread commercial availability of endovascular de-
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formed. Patients with both infrarenal and juxtarenal (de-
fined as having an infrarenal neck of some length to allow
creation of an infrarenal anastomosis) aneurysms were in-
cluded, whereas those with suprarenal, type IV thoracoab-
dominal aneurysms and those treated for aortoiliac occlu-
sive disease were not. Frank ruptures were also excluded
from analysis. The Institutional Review Board of the Mas-
sachusetts General Hospital approved this clinical protocol.
Demographic and preoperative, perioperative, and
postoperative data, including clinical presentation, aneu-
rysm extent, operative conduct, and complications, were
recorded from a review of office records and institutional
electronic medical records. Renal insufficiency was defined
as a creatinine level of 1.5 mg/dL or more, and although
most patients underwent formal cardiac risk stratification
before open repair, the retrospective determination of car-
diac function was limited to a history of myocardial infarc-
tion (MI) regardless of the status of coronary revasculariza-
tion. Clinical evidence of chronic obstructive pulmonary
disease was documented when present clinically; however,
patients were investigated with formal pulmonary function
testing only when symptoms were obviously disabling.
Surgical considerations. Patients were approached
through a left flank or midline transabdominal incision
according to surgeon preference. Comprehensive resection
of the AAA was performed with the anatomic intent of
placing, in particular, the proximal anastomosis in grossly
normal aorta, which has led to an aggressive posture of
suprarenal clamping (approximately 25%) to achieve this
goal. The proximal anastomosis was created in an end-to-
end fashion, incorporating one or both renal artery origins
for the juxtarenal AAA. In addition, aorta to left renal artery
bypass with a prosthetic graft was performed in 27 patients,
with the right renal artery incorporated into the proximal
anastomosis. The site of distal anastomosis was based on
surgeon preference and was determined by data from pre-
operative imaging studies.
Postprocedure follow-up. Perioperative mortality
was defined as any death within 30 days of the procedure or
any death occurring during the initial hospitalization. Early
and long-term events were identified through a review of
office charts and the hospital’s computerized medical
record. Additional information regarding patient survival
was obtained from the Social Security Death Index. The
269 patients who remained alive were contacted by tele-
phone to arrange follow-up surveillance imaging. This con-
sisted of a dedicated fine-cut computed tomography angio-
gram of the chest, abdomen, and pelvis in most patients.
Those with a history of renal insufficiency, diabetic ne-
phropathy, or known contrast allergy were alternatively
imaged with a magnetic resonance angiogram. A staff radi-
ologist blinded to the anatomic details of the AAA resection
then evaluated these studies. The designation of an arterial
segment as aneurysmal was based on the following criteria:
thoracic aorta/visceral aorta (4 cm), visceral vessels (2
cm), and iliac/femoral arteries (2 cm). Study end points
included freedom from graft-related interventions and an-eurysm-related and overall survival. Aneurysm-relatedmor-
tality included death from any cause within 30 days of the
primary AAA procedure, death within 30 days of any sec-
ondary procedure related to the aneurysm, or any death
due to aneurysm rupture. Finally, the frequency of second-
ary graft-related procedures was determined, as well as the
time, method, and success of such reinterventions.
Statistical analysis. Actuarial survival analysis was per-
formed using Kaplan-Meier life tables with Mantel-Cox
log-rank univariate methods to identify differences be-
tween groups. Relative risk and confidence intervals (CIs)
were then determined using a multivariate Cox propor-
tional hazards model for data with variable follow-up. A
logistic regression model was used for multivariate analysis
of perioperative outcomes. Variables used in the multivar-
iate models included age, sex, diabetes, a history of MI,
proximal clamp placement, congestive heart failure, renal
insufficiency, steroid use, and a history of chronic obstruc-
tive pulmonary disease. A P value of .05 was considered
significant for all statistical analysis.
RESULTS
During the study period, 579 patients underwent open
AAA repair, of which 39 frank ruptures were excluded from
further analysis, thus leaving a cohort of 540 patients.
Demographic and clinical factors are summarized in Table
I. The mean abdominal aortic diameter was 58.9 mm
(range, 49-100 mm). The proximal cross-clamp position
was suprarenal in 25% and infrarenal in the remaining 75%.
All patients had prosthetic grafts placed, most of which
(96%) were Dacron (DuPont, Wilmington, Del). A straight
prosthesis was placed in 47% of patients, and the remaining
53% had bifurcated reconstructions. The distal target for
the bifurcated grafts was the iliac arteries in 41% and
femoral arteries in 12% of all patients. Operative data are
summarized in Table II.
The perioperative mortality rate was 3% (n  17), and
major complications occurred in 56 (10%) patients (Table
III), so overall perioperative morbidity and mortality oc-
curred in 68 (13%) patients. Factors predictive of postop-
Table I. Demographic and clinical data
Variable Data
No. patients 540
Male sex 411 (76%)
Age, y, mean (range) 73 (37-98)
Hypertension 367 (68%)
History of MI 191 (25%)
COPD 68 (13%)
Diabetes 42 (8%)
Renal insufficiency 58 (11%)
History of stroke 48 (9%)
Current smoker 86 (16%)
Former smoker 259 (48%)
Steroid use 18 (3%)
MI, Myocardial infarction; COPD, chronic obstructive pulmonary disease.erative complications (including perioperative mortality) as
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MI (hazard ratio [HR], 2.04; 95% CI, 1.17-3.57; P .01)
and renal insufficiency (HR, 2.5; 95% CI, 1.18-5.32; P 
.02).
The average follow-up for all patients was 87 months
(range, 1 month to 11.5 years), and 269 (50%) patients
remain alive. The overall actuarial survival was 70.7% 2%
and 44.3% 2.4% at 5 and 10 years, respectively. Negative
predictors of long-term survival identified by the multivar-
iate model included age at operation (HR, 1.06; 95% CI,
1.04-1.08; P  .001), history of MI (HR, 1.37; 95% CI,
1.06-1.78; P  .02), congestive heart failure (HR, 1.57;
95% CI, 1.01-2.43; P .04), and preoperative renal insuf-
ficiency (HR, 1.51; CI, 1.02-2.22; P  .04). There were
eight late aneurysm-related deaths: five occurred after dis-
charge at a rehabilitation facility, two were secondary to
ruptured thoracic aneurysms, and one patient died from
complications related to removal of an infected graft 4 years
after the original operation. The actuarial freedom from
aneurysm-related death was 95.7%  0.9% and 95.2% 
0.9% at 5 and 10 years, respectively. Multivariate analysis
failed to yield evidence that any candidate variable was a
Table II. Operative data (n  540)











Iliac arteries 221 (41%)
Femoral arteries 63 (12%)
PTFE, Polytetrafluoroethylene.
Table III. Perioperative outcomes (n  540)
Postoperative complications Data
Renal insufficiency 35 (6%)
Dialysis 3 (1%)
Return to OR 32 (6%)
Myocardial infarction 13 (2%)
Stroke 7 (1%)
DVT/PE 5 (1%)
ICU stay, d, mean (range) 2.1 (1–35)
Transfusion units, mean (range) 1.3 (0–22)
Hospital stay, d, median (range) 7 (0–100)
Disposition
Death (mortality) 17 (3%)
Discharge home 406 (75%)
Rehabilitation facility 117 (22%)
Renal insufficiency was defined as a doubling of baseline creatinine or an
absolute level 3.0 mg/dL.
OR,Operating room;DVT, deep vein thrombosis; ICU, intensive care unit.significant independent predictor of aneurysm-relateddeath. There were 13 graft-related complications identified
in 11 patients, including 7 anastomotic pseudoaneurysms
(4 proximal and 3 distal). Three of the four proximal and
two of the three distal cases underwent open operative
repair. The remaining two were observed because of con-
comitant comorbidities. There were four graft limb occlu-
sions in the bifurcated grafts that were treated with open
thrombectomy and revision of the distal (femoral) anasto-
mosis. Finally, two graft infections were identified and
treated with graft removal. Freedom from graft-related
reintervention was 98.2%  0.8% and 94.3%  3.4% at 5
and 10 years, respectively. No independent predictor of
graft-related reintervention was identified by the multivar-
iate model.
Surveillance imaging (mean 7.2 years after operation)
was obtained for 152 (57%) of the 269 patients who
remained alive. Additional aneurysms were identified in
noncontiguous arterial segments in 68 (45%) of 152 pa-
tients (25 proximal to graft and 43 distal to the graft), and
29 (19%) patients had multiple aneurysms. The distribu-
tion of aneurysmal arterial segments is summarized in Fig 1.
Ten of these aneurysms were treated according to the
discretion of the operating surgeon. Three of the 12 iliac
aneurysms larger than 2.5 cm were repaired with stent
grafts, 3 of the 6 visceral segment aneurysms larger than 5.5
cm underwent open repair, and 4 of the 9 thoracic aneu-
rysms greater than 5.5 cm were repaired—2 for contained
ruptures. Independent predictors of having multiple addi-
tional aneurysms included age (HR, 0.92; 95% CI, 0.87-
0.99; P  .02), history of MI (HR, 8.7; 95% CI, 2.85-
26.59; P .0001), and renal insufficiency (HR, 7.31; 95%
CI, 1.15-46.61; P  .04).
DISCUSSION
Since the initial EVAR performed at our hospital in
1994, the debate relative to the compromise between im-
proved perioperative morbidity and mortality and uncer-
tain long-term durability of EVAR has evolved consider-
Fig 1. Distribution of additional aneurysmal arterial segments
identified by surveillance imaging in 68 of 152 patients. Visceral
and thoracic refer to the corresponding segments of the aorta.ably. Impressed with EVAR results in clinical trial data, we
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age of patients after Food and Drug Administration ap-
proval in 1999, and indeed, recently reported data from our
institution indicate that in the calendar year 2005, 70% of
our AAA repairs were performed with EVAR.10
Reduced morbidity and mortality with EVAR com-
pared with open AAA is documented with level I evi-
dence.6,12,17 As anticipated, particular benefit is seen in
high-risk patients.11 Clinically relevant late outcomes are
also favorable except for a 10% to 14% need for secondary
interventions.10,18,19 Because EVAR and open repair are
compared with short-term and intermediate follow-up, the
early advantage of lower perioperative morbidity and mor-
tality seen with EVAR may be negated by the need for
long-term surveillance, frequent reinterventions, and the
perhaps undue emphasis on a lack of a late survival benefit
after EVAR.10,18,20 However, the advantage in periopera-
tive mortality seen with EVAR is apparent neither in single-
center studies nor in our own experience. Contemporary
series with EVAR indicate perioperative mortality rates
ranging from 1.2% to 3% in patients who were considered
fit for open repair.6,12,21 These figures are then often
compared with open mortality rates exceeding 5% (partic-
ularly in administrative database studies),22 thus promul-
gating the notion that EVAR is safer in the perioperative
period. Indeed, a recent survey of the National Surgical
Quality Improvement Program database showed that after
risk-adjusted analysis, the 30-day morbidity and mortality
of open repair were more than twofold higher than those of
EVAR.11 In this series, the perioperative mortality of 3%
encompassed all patients, including those who required a
suprarenal clamp for repair, and compares favorably to rates
in recent reports, which range from 1.2% to 4.5%.11,14,16
We recently reported our experience with 873 EVARs per-
formed over 12 years with a perioperative mortality of 1.8%,
which was not significantly different when compared with our
open AAA perioperative mortality data (P .11).10
The reintervention rate after EVAR has become an
increasing problem as results with longer follow-up have
become available, thus leading some to question the long-
term effectiveness of stent-graft repair.18 However, propo-
nents of EVAR emphasize that reinterventions are fre-
quently catheter based and minimally invasive, whereas
graft-related complications after open repair are a potential
source of considerable additional morbidity. Indeed, a re-
cent report comparing mid-term results of EVAR vs open
repair found an 11% graft-related reintervention rate at 20
months for open procedures that equated to a 22% addi-
tional morbidity.5 However, half of the patients requiring
graft-related reinterventions were initially treated at refer-
ring institutions; thus, the denominator of patients under-
going open AAA repair should have included all operations
from referring surgeons and not just the reporting institu-
tion. These data seemed unbelievable to us, given the
methodologic flaws, and indeed were (in part) the impetus
for this study.
The perceived excellent durability of open AAA is in-
deed substantiated in the literature and the data presentedherein. Hertzer et al16 reported rare graft-related compli-
cations (0.4%) with 5-year follow-up, although only clini-
cally evident (as opposed to computed tomography scan–
detected) events were considered. Our graft-related
complication rate is also low, with a 94.6% freedom from
graft-related reintervention at 10 years. Adam et al13 re-
ported a low (3.4%) reintervention rate with an average
follow-up of 3.4 years, with most being either anastomotic
pseudoaneurysms or graft limb thromboses. However,
their surveillance period was inadequate because patients
without evidence of complications at the 6-week postoper-
ative visit were discharged from anatomic follow-up. Hal-
lett et al15 reported a 9.4% graft-related complication rate
(mostly anastomotic pseudoaneurysms) after open AAA
repair at an average follow-up of 5.8 years with late surveil-
lance imaging on most patients. Finally, Biancari and col-
leagues’ report14 of a 15.4% late graft-related complication
rate with amedian follow-up of 8 years is significantly worse
than the previous reports and may be related to the inclu-
sion of ruptured AAA repairs, wherein comprehensive an-
eurysmectomy may not be performed because of the nu-
ances of treating ruptured AAAs. However, the duration of
follow-up is not the sole predictor of graft-related compli-
cations, because series with reasonable follow-up have
few.16 The differencemay be related to surgeon experience,
because high-volume institutions tend to report excellent
outcomes. Of note, the most common complications re-
ported among all cohorts were anastomotic pseudoaneu-
rysms and graft limb thromboses.
In contrast to the long-term data associated with open
repair, durability studies of EVAR have typically had rela-
tively short surveillance intervals, with most reports averag-
ing less than 24 months of follow-up.19-22 Despite this, the
reintervention rates have ranged from 8.7% at 12 months
(from the EUROSTAR study19) to 27% at 18 months.22
Thus, as intuitively expected, graft-related reintervention is
higher in patients undergoing EVAR than in those with
open repair. Indeed, in consideration of our own data, the
freedom from reintervention after EVAR was significantly
lower than that after open repair at 5 years (78.2% vs 98.2%;
P  .0001; Fig 2).10 However, most events leading to
secondary intervention after EVAR involved endoleaks,
and most of these were managed percutaneously or endo-
vascularly via a groin incision. Despite the minimally inva-
sive nature of reinterventions, frequent admissions for
treatment-related complications essentially negate the
shorter hospital length of stay enjoyed by EVAR over open
repair in the perioperative period.20 Yet most operators
accept the higher reintervention rates associated with
EVAR for the benefit of reduction in periprocedural mor-
bidity.
One argument favoring EVAR for the treatment of
AAA is that survival rates in AAA patients are remarkably
less than expected for the general age- and sex-adjusted
population.15 However, 5- and 10-year survival rates have
been surprisingly similar after open AAA repair across three
decades (66% and 35%, respectively). Indeed, our overall
survival rates of 70.7% and 44.3% are consistent with this
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data, survival after open repair was significantly higher at 5
and 10 years (70.7% vs 52.1% at 5 years and 44.3% vs 16.8%
at 10 years; Fig 3).10 This almost certainly represents a
selection bias, because EVAR has been offered to and
performed on patients who were not considered open
surgical candidates. Sicard et al23 recently reported data
from the Society of Vascular Surgery registry that showed
EVAR to be safe in high-risk patients, with no difference in
all-cause mortality between EVAR and open controls at 4
years. These results are consistent with ours, because sur-
vival curves between the open and EVAR cohorts did not
diverge until after 4 years of follow-up (Fig 3). This phe-
nomenon may further be explained by the fact that al-
though the mean ages were the same between the EVAR
and open cohorts, differences were noted in extremes of
age: 31% of patients undergoing EVAR were older than 80
years of age, compared with only 19% in the open group.
Indeed, when the analysis of survival after open repair was
stratified by age, a predictable difference was seen such that
patients 75 years of age or younger have a 51.4% actuarial
10-year survival, compared with 32.4% for patients older
than 75 years (Fig 4). This longer life expectancy in
younger patients lends support to the continued practice of
Variable
Time
0 1 2 3 4 5 6 7 8 9 10
At risk
Open 540 311 284 243 219 196 168 132 80 48 24
EVAR 873 851 568 358 215 134 73 37 19 3
Survival (%)
Open 99.8 99 99 98.6 98.2 98.2 97.6 97.6 97.6 97.6 94.3
EVAR 97.2 91.1 85 82.1 78.2 71.4 68.9 62.9 62.9
SE
Open 0.2 0.5 0.5 0.6 0.8 0.8 0.9 0.9 0.9 0.9 3.4
EVAR 0.6 1.2 1.7 2.0 2.6 3.7 4.4 7.0 7.0
Fig 2. Kaplan-Meier estimate for patients’ freedom from graft-
related interventions after open vs endovascular (EVAR) repair of
abdominal aortic aneurysms (P value determined by Mantel-Cox
log-rank univariate analysis). EVAR data are taken from Brewster
et al.10performing open AAA repairs on young or healthy patientswhile reserving EVAR for patients of advanced age or those
who have comorbidities that place them at higher operative
risk. However, factors such as patient preference and risk of
sexual dysfunction will influence decision making in indi-
vidual patients irrespective of the data presented herein.
The relatively low graft-related complication rate after
open AAA repair has led some authors to conclude that
postoperative surveillance is unnecessary.14 This study does
not support this approach. Hallett et al15 identified true
aneurysmal degeneration (3 cm) above previous aortic
grafts in 13% of patients, and Biancari et al14 identified
noncontiguous aortic aneurysms in 22% of patients during
follow-up. Upon further evaluation of our cohort, addi-
tional aortic aneurysms (4 cm) were noted in 24% of
patients with late surveillance imaging. These aneurysms
were documented on the basis of strict anatomic criteria
that were not stratified by sex, and, indeed, many additional
aneurysms were not of sufficient diameter to necessitate
intervention at diagnosis. However, it is clear that these
patients warrant continued surveillance.
The finding of renal insufficiency as a negative predictor
of survival and postoperative complications is an observa-
tion noted repeatedly in the literature on AAA repair16,24,25
and should figure prominently in clinical decision making.
It has also been shown to be a negative predictor of survival
Time
Variable 0 1 2 3 4 5 6 7 8 9 10
At risk
Open 540 491 476 455 424 382 343 290 202 145 80
EVAR 873 865 584 395 259 173 104 59 27 6
Survival (%)
Open 97 90.9 88.1 84.3 78.3 70.7 63.7 57.5 51.7 48 44.3
EVAR 92.6 83.4 72.9 63.4 52.1 42.3 30.5 22.4 16.8
SE
Open 0.7 1.2 1.4 1.6 1.8 2.0 2.1 2.1 2.2 2.3 2.4
EVAR 1.0 1.5 2.0 2.4 2.8 3.1 3.5 4.0 5.7
Fig 3. Kaplan-Meier estimate for survival of patients undergoing
open repair of abdominal aortic aneurysms vs endovascular repair
(EVAR; P value determined by Mantel-Cox log-rank univariate
analysis). EVAR data are from Brewster et al.10after EVAR.10 Indeed, renal insufficiency and end-stage
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in both the general and vascular disease populations.26 In
our view, these considerations make EVAR the procedure
of choice in the presence of chronic renal insufficiency.
When evaluating a retrospective study, it is important
to consider the inherent limitations that accompany the
associated results. Although the cause of most deaths was
captured during this review, there is a group of patients
who have been confirmed deceased by the Social Security
Death Index, but the cause is unknown, and it is possible
that some of these deaths were secondary to graft-related
complications. Therefore, aneurysm-related mortality may
be underestimated. This flaw in follow-up is partially adju-
dicated by the Kaplan-Meier life-table analysis. It is also
difficult to determine the true morbidity of open aneurysm
repair because there was little information regarding oper-
ation-related events. It is likely that patients who developed
late bowel obstructions or incisional hernias were treated at
their referring institutions. Finally, the identification of
subsequent aneurysms on surveillance imaging may be
falsely increased because gender was not factored into the
analysis of vessel diameter and because preoperative imag-
ing was not readily available. Indeed, there are no consen-
sus guidelines for gender-related management of iliac an-
eurysms, and small (2-cm) vessels may have been
Time
Variable 0 1 2 3 4 5 6 7 8 9 10
At Risk
75 y 339 312 307 297 282 258 238 206 144 100 60
75 y 201 179 169 160 142 124 105 86 59 40 20
Survival (%)
75 y 96.8 92 90.6 87 83.2 76.1 70.2 64.9 58.7 56 51.4
75 y 97.5 89.1 84.1 79.6 70.1 61.7 52.7 45.1 39.8 34.5 32.4
SE
75 y 1.0 1.5 1.6 1.8 2.0 2.3 2.5 2.6 2.7 2.8 3.1
75 y 1.1 2.2 2.6 2.8 3.2 3.4 3.5 3.5 3.5 3.6 3.7
Fig 4. Kaplan-Meier estimate for survival of patients undergoing
open repair of abdominal aortic aneurysms as stratified by age (P
value determined by Mantel-Cox log-rank univariate analysis).considered inconsequential at the time of open AAA.CONCLUSION
Despite recent suggestions to the contrary, open repair
remains a safe and durable option for the management of
AAA, with an excellent associated 10-year survival in
younger patients. When open AAA repair is performed in
high-volume centers, the perioperative mortality of appro-
priately selected patients is no different from that of EVAR.
In addition, the freedom from graft-related reintervention
after open AAA repair is superior to that of patients treated
with EVAR. Finally, intermittent, long-term surveillance
after open repair is appropriate and should be directed
toward detection of other aneurysms. These data support
the continued practice of offering open AAA repair to
younger, good-risk patients with the acknowledgment that
individual patient preference and anatomy will profoundly
influence the choice of operation.
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